Every recall we track for Dr. Reddy's Laboratories, Inc. — 163 in all — plus the complaints and injury reports the public filed about them.
Dr. Reddy's recalls 1mg Varenicline tablets due to subpotent drug levels found in a specific lot during stability testing. This may affect prescription medication efficacy.
Dr. Reddy's recalls 25 vials of Succinylcholine Chloride Injection due to decreased preservative concentration found during stability testing. This may affect medication safety.
Dr. Reddy's recalls 20mg omeprazole capsules with foreign Divalproex Sodium tablets. Consumers should check NDC 82009-022-10 and lot C2403017 for affected products.
Dr. Reddy's recalls Levetiracetam 0.75% Sodium Chloride Injection due to incorrect labeling that could lead to wrong medication use. Affected units have specific NDC and lot numbers.
Dr. Reddy's recalls 100mg Javygtor tablets due to failed impurities/degradation. Affected lots expire by 08/31/2025. Stop using if you have these specific lots.
Dr. Reddy's recalls 30mg Morphine Sulfate Extended-Release Tablets due to failed impurities specification. Rx-only bottles with specific lot number and expiration date.
Dr. Reddy's recalls 15mg Morphine Sulfate Extended-Release Tablets due to failed impurities specification. Rx-only product manufactured by Mayne Pharma. No remedy specified in official notice.
Dr. Reddy's recalls 30mg Cinacalcet tablets with N-nitroso impurity above FDA limits. Affected lots manufactured in India, expiring through 2026. No remedy stated in official notice.
Dr. Reddy's recalls 90mg Cinacalcet tablets with potential N-nitroso impurity above FDA limits. Rx-only medication may pose health risks. Check NDC 43598-369-30 and lot numbers for affected batches.
Dr. Reddy's recalls 600mg ibuprofen tablets (Rx only) due to impurities exceeding safety limits. Consumers should check NDC codes and expiration dates for affected lots.
Dr. Reddy's recalls 400mg Ibuprofen tablets (Rx only) due to impurities exceeding safety limits. Affected lots have specific NDC numbers and expiration dates. Consumers should contact the manufacturer for details.
Dr. Reddy's recalls Sevel: 0.8g oral suspension packets with missing lot and expiration dates. Consumers should check labels for correct dates to avoid potential safety issues.
Dr. Reddy's Laboratories recalls 300mg allopurinol tablets for foreign substance presence. Rx-only medication with NDC 55111-730-01. No remedy specified in official notice.
Dr. Reddy's recalls 1mg Eszopiclone tablets due to potential impurities. Affected lots: C2302598, expiring 2/29/2025. No specific remedy stated in recall notice.
Dr. Reddy's recalls Zoledronic Acid 5mg/100mL vials due to leaking, risking contamination. Affected lots: G3000010, expiring 11/2025. Contact for details.
Dr. Reddy's recalls 100-count Sirolimus 1mg tablets (NDC 55111-653-01) due to failed impurities and degradation. Rx-only tablets distributed in the US from India. No specific remedy stated in recall.
Dr. Reddy's recalls Javygtor (sapropterin dihydrochloride) powder for oral solution due to discoloration indicating decreased potency. Patients should contact their doctor for guidance.
Dr. Reddy's recalls 100mg Sapropterin Dihydrochloride Powder for Oral Solution due to potential decreased potency from discoloration. Affected units have specific lot numbers and expiration dates.
Dr. Reddy's recalls 100-count Glimepiride tablets (1mg) due to a misprint on the tablets, which could lead to incorrect dosing. Affected lots were manufactured in India with specific expiration dates.
Dr. Reddy's recalls 1mg Glimepiride tablets due to potential misprint on labels. This could lead to incorrect dosing. Affected products have specific NDC and lot numbers. Contact for remedy details.
Dr. Reddy's recalls 4mg tizanidine tablets with foreign 2mg tablets. Consumers should check NDC 55111-180-15 and lot T2304007 for affected products.
Dr. Reddy's recalls 100-count Tacrolimus capsules (1mg) due to foreign tablets found in some bottles. This is a medication for immunosuppression.
Dr. Reddy's recalls 1000-count Montelukast Sodium Tablets due to foreign metoprolol tablets found in some bottles. Consumers should check product details and contact the company for guidance.
Dr. Reddy's recalls 0.5mg Tacrolimus capsules due to foreign 1mg capsules in some bottles. This may cause incorrect dosing. Check your bottle's lot number and contact for details.
Dr. Reddy's recalls Allergy Relief D tablets that may not dissolve properly, potentially affecting medication effectiveness. This recall covers specific lot numbers and packaging sizes sold through Walmart.
Dr. Reddy's recalls 10 mg/mL Phytonadione Injectable Emulsion due to stability issues at 12-month testing. This may affect medication safety. Check NDC 43598-405-16 and lot numbers for affected products.
Dr. Reddy's recalls 35mg Lansop: tablets may not dissolve properly, causing ineffective treatment. Check NDC 43598-561-78 or lot T2100515 for affected products.
Dr. Reddy's recalls 30mg Lansoprazole tablets due to failed dissolution specifications. This may affect medication effectiveness. Check your product details and contact the manufacturer for guidance.
Dr. Reddy's recalls 15mg Lansoprazole Delayed-Release Capsules due to failed dissolution specifications in long-term stability testing. This affects specific bottle counts and expiration dates.
Dr. Reddy's recalls 30mg Lansoprazole capsules due to failed dissolution testing. This may affect medication effectiveness. Contact for return instructions.
Dr. Reddy's recalls 80mg Atorvastatin Calcium tablets with impurities that could cause harm. Affected lots from India, expiring 2022-2023. Stop using and contact for details.
Dr. Reddy's recalls 100mg Sapropterin Dihydrochloride Powder for oral solution due to subpotent drug results. This may not provide intended treatment. Check NDC 43598-477-11 or 43598-477-30 for affected products.
Dr. Reddy's recalls 3.5 mg/vial Bortezomib vials due to failed stability specifications. This may affect medication safety. Check NDC 43598-865-60 and lot numbers for affected products.
Dr. Reddy's recalls certain Azacitidine 100mg vials due to failed stability specifications. These vials may degrade over time, potentially affecting drug safety. Contact the manufacturer for details.
Dr. Reddy's recalls certain Azacitidine vials due to failed stability specifications. This may affect drug effectiveness and safety. Check NDC 43598-305-62 and specific lot numbers for affected products.
Dr. Reddy's Laboratories recalls Mucus Relief D tablets due to subpotent drug content. Affected lots from 2023-04 expiration date. Consumers should check packaging for NDC 0363-164-3 and lots AT2102065A/B.
Dr. Reddy's Allergy Relief-D tablets with failed dissolution specifications are being recalled from Kroger stores. This recall addresses potential safety concerns with the medication's effectiveness.
Dr. Reddy's Leader allergy and congestion relief tablets with failed dissolution specifications are being recalled. This may affect safety and effectiveness of the medication.
Dr. Reddy's recalls allergy and congestion tablets with potential dissolution failure. Consumers should check lot numbers and expiration dates for affected batches.
Dr. Reddy's recalls certain fexofenadine and pseudoephedrine extended-release tablets due to failed dissolution specifications. Affected lots and UPCs are listed; consumers should contact the manufacturer for details.
Dr. Reddy's Wal-Fex D extended-release tablets with failed dissolution specifications may not work as intended. Recall includes specific lot numbers and box sizes.
Dr. Reddy's Rugby antihistamine and nasal decongestant tablets with failed dissolution specifications are being recalled. This recall addresses potential safety concerns with the product's effectiveness.
Dr. Reddy's recalls Allergy Relief D tablets with failed dissolution specs. Affected lots from 2022-2023. Stop using if you have these NDC numbers.
CVS Health recalls Allergy Relief D tablets with failed dissolution specifications. These extended-release tablets may not dissolve properly, potentially causing ineffective treatment. Affected lots and UPCs listed.
Dr. Reddy's QC QUALITY CHOICE extended-release allergy tablets with failed dissolution specifications are recalled. Consumers should check NDC 63868-729-10 and lot numbers 79C002624D/79C002625C.
Dr. Reddy's Laboratories recalls Allergy Relief D 60mg Fexofenadine/120mg Pseudoephedrine Extended-Release Tablets due to failed dissolution specifications. No remedy stated in official notice.
Dr. Reddy's recalls 20-tablet allergy/congestion medication due to failed dissolution specifications. Consumers should check NDC 43598-823-14 and lot numbers for affected products.
Dr. Reddy's Laboratories recalls Allergy Relief D tablets with failed dissolution specifications. Consumers should check NDC 69842-249-30 and lot number AC2103329C for affected units.
Dr. Reddy's recalls Allergy Relief D tablets with failed dissolution specifications. These tablets may not release medication properly, potentially reducing effectiveness. Check NDC 69842-249-20 and lot number AC2103329I for affected units.
Dr. Reddy's recalls allergy/congestion tablets with failed dissolution specs. These tablets may not release medication properly. Consumers should contact Dr. Reddy's for details.
Dr. Reddy's recalls 20-count allergy and congestion tablets with failed dissolution specifications. This may affect medication effectiveness. Contact Rite Aid for details.
Dr. Reddy's recalls extended-release allergy and congestion tablets due to failed dissolution specifications. Consumers should check NDC 0536-1242-34 and lot number AC2103329H for affected products.
Dr. Reddy's recalls extended-release allergy and congestion tablets due to failed dissolution specifications. Affected lots may not release medication properly, causing ineffective treatment. Check NDC 0638-1242-07 and lot numbers for affected products.
Dr. Reddy's recalls 12HR allergy relief tablets with failed dissolution specifications. Consumers should check NDC 70000-0518-1 and lot AC2103329G for affected units.
Dr. Reddy's Ezetimibe and Simvastatin 10mg/10mg tablets (90 and 1000 count) recalled due to failed excipient specifications. Product may have conductivity issues affecting safety.
Dr. Reddy's recalls 500-count Ezetimibe and Simvastatin tablets (10mg/40mg) due to foreign tablets found in some bottles. Rx-only medication manufactured in Shreveport, LA.
